Medicine and Dentistry
Neoplasm
100%
Non Small Cell Lung Cancer
56%
Colorectal Carcinoma
39%
Computer Assisted Tomography
35%
Lung Adenocarcinoma
30%
Lung Cancer
30%
Gene Mutation
28%
Adenocarcinoma
25%
Clear Cell Renal Cell Carcinoma
24%
Epidermal Growth Factor Receptor
23%
Transitional Cell Carcinoma
20%
Anthracycline
19%
Cardiac Magnetic Resonance Imaging
19%
Cardiotoxicity
19%
Lymph Node
17%
Lung
14%
Recurrent Disease
13%
Carcinoma
12%
Circulating Tumor DNA
11%
Biological Marker
11%
Lung Nodule
11%
Fluorodeoxyglucose F 18
11%
Connective Tissue Cancer
11%
Immunohistochemistry
11%
Disease Exacerbation
11%
Cancer Mortality
11%
Tumor Cell
10%
Prognostic Factor
9%
Formaldehyde
9%
Receptor Gene
9%
Left Ventricle
9%
Fine-Needle Aspiration
9%
Adjuvant Chemotherapy
9%
Hemangioma
9%
Tattooing
9%
Retrospective Study
9%
Silicosis
9%
Cystadenoma
9%
Pneumoconiosis
9%
Treatment Response
9%
Differential Diagnosis
9%
Endoscopic Ultrasound Guided Fine Needle Biopsy
9%
Idiopathic Interstitial Pneumonia
9%
Vestibule of the Ear
9%
Hamartoma
9%
Oligoastrocytoma
9%
Ground Glass Opacity
9%
Anaplastic Lymphoma Kinase
9%
Spontaneous Remission
9%
Magnetic Resonance Imaging
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
35%
Non Small Cell Lung Cancer
23%
Lung Adenocarcinoma
20%
Cardiotoxicity
19%
Anthracycline
19%
Colorectal Carcinoma
19%
Epidermal Growth Factor Receptor
17%
Lung Cancer
16%
Anaplastic Lymphoma Kinase
14%
Overall Survival
11%
Primary Tumor
11%
Disease Exacerbation
11%
Carcinoma
10%
Metastasis
9%
Fluorodeoxyglucose F 18
9%
Rat Model
9%
Matrix Metalloproteinase 14
9%
Brain Cancer
9%
Dipeptidyl Peptidase
9%
Astrocytoma
9%
Interstitial Pneumonia
9%
Circulating Tumor DNA
9%
Polyethylene Terephthalate
9%
Lymph Node Metastasis
8%
Doxorubicin
8%
Cancer Mortality
8%
Progression Free Survival
7%
Adenocarcinoma
7%
Fibrosis
6%
Dipeptidyl Peptidase IV
6%
Heart Muscle Injury
5%